Cas:884494-70-6 2-Chloro-4-methylpyridin-3-ol manufacturer & supplier

We serve Chemical Name:2-Chloro-4-methylpyridin-3-ol CAS:884494-70-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-Chloro-4-methylpyridin-3-ol

Chemical Name:2-Chloro-4-methylpyridin-3-ol
CAS.NO:884494-70-6
Synonyms:2-chloro-4-methylpyridin-3-ol
Molecular Formula:C6H6ClNO
Molecular Weight:143.57100
HS Code:2933399090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:325.319ºC at 760 mmHg
Density:1.313g/cm3
Index of Refraction:1.572
PSA:33.12000
Exact Mass:143.01400
LogP:1.74900

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-chloro-4-methylpyridin-3-ol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-chloro-4-methylpyridin-3-ol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-chloro-4-methylpyridin-3-ol Use and application,2-chloro-4-methylpyridin-3-ol technical grade,usp/ep/jp grade.


Related News: According to the 2013-2018 New Drug Review Summary report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years. 2-Chloro-4-methylpyridin-3-ol manufacturer This also includes its anti-tau pipeline, with the FDA’s approval having “implications for AD programmes targeting Tau,” according to Jefferies. 2-Chloro-4-methylpyridin-3-ol supplier Under the sub-licensing agreement, Mankind will market the drug under its own trademark while Glenmark will manufacture and supply it to the drug firm. 2-Chloro-4-methylpyridin-3-ol vendor According to the 2013-2018 New Drug Review Summary report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years. 2-Chloro-4-methylpyridin-3-ol factory A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018.